FFA
SLDB icon

Farther Finance Advisors’s Solid Biosciences SLDB Stock Holding History

Farther Finance Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Buy
5,531
+4,311
+353% +$32.7K ﹤0.01% 3180
2026
Q1 		$9K Buy
1,220
+846
+226% +$5.44K ﹤0.01% 4179
2025
Q4 		$2.11K Sell
374
-11,123
-97% -$60.3K ﹤0.01% 4675
2025
Q3 		$70.9K Buy
+11,497
New +$67.2K ﹤0.01% 2250

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Farther Finance Advisors's SLDB Position: Q2 2026 in Review

Farther Finance Advisors increased its Solid Biosciences (SLDB) stake by 353% in Q2 2026, buying an estimated $32.7K and bringing the position to 5,531 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

Farther Finance Advisors first reported a position in SLDB in Q3 2025 and has held it in 4 quarters since. The position peaked at $70.9K in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Farther Finance Advisors held 5,531 shares of Solid Biosciences worth $55K as of Q2 2026.
  • Farther Finance Advisors bought 4,311 Solid Biosciences shares in Q2 2026, an estimated $32.7K.
  • Solid Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3180 holding.
  • Farther Finance Advisors first reported a position in Solid Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Solid Biosciences position peaked at $70.9K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.